News

Congratulations to Tessa, Valerie and team! They published their exciting drug targeting manuscript on Interleukin 4 in a mouse model system of arthritis in the Journal of Controlled Release.

Congratulations to Marco, Niclas & team! The detailed the antibacterial efficacy of some Anacardic Acid derivatives in their manuscript just coming online with ACS Infections Diseases!

We congratulate Tobias for his publication in ACS Biomaterials resulting from his coop with Dr. Wimschneider and Prof. Brehm from the University of Erlangen! The publication covers unorthodox approaches leading to easy to handle and distribute diagnostics - a feature particularly interesting in our current days! The contribution was selected for "Editor's choice" and is available free of charge on the ACS homepage.

Congratulation to Thomas and Matthias for their publication in ACS Omega detailing easy approaches to handle alginate for bioprinting applications and future biofabrication.

Visualizing biodistribution pattern of PEGylated FGF-2 in vivo - Congratulations to Tessa and Marcus, who published in vivo performances of novel FGF-2 bioconjugates together with partners from the Paul Scherrer Institute in Switzerland.

A group of five doctoral students and Professor Meinel attended the annual meeting of the German local chapter of the Controlled Release Society in Munich.

A chewing gum that warns of inflammation in the oral cavity: Scientists at the University of Würzburg have been focusing on this clever idea for a long time.

News regarding the effect of carbon monoxide on neuroprotection following cardiac arrest and extracorporeal resuscitation! Congratulations to Jakob and team for a superb study outlining the potential of CO in the American Journal of Physiology!”

In cooperation with Ann-Christin Pöppler, we published an article detailing the decrease in dissolution with increasing drug loading of polymer micelles on a molecular level.

PD Dr. Tessa Lühmann has been elected as expert of group 6 at the European Pharmacopeia. Group 6 is responsible for Biological and Biotechnological products.